Unconquerable fortress of Januvia substance patent defeats domestic pharmaceuticals

The wall of substance patent was sturdy. Like ‘Baraclude,’ ‘Januvia,’ a diabetic treatment, succeeded in defending its substance patent from other challenges. The nullity request against the extension of the term of the patent right, filed by Jeil Pharmaceutical and Yungjin Pharm, was defeated.

According to the pharmaceutical industry on the 24^th, the Intellectual Property Tribunal dismissed t...